Paull hopper has gathered a team of money makers again ...
jennifer chow chief operating officer,
dr syed rizvi chief medical officer
dr eliot bourk head of business and corp development... all were with celgene when.....
At least 30 companies globally are developing CAR-T therapies and billions of dollars are being invested into the field. In 2017 Gilead Sciences bought cell therapy business Kite Pharma for $US11.9 billion, and in 2018 Celgene bought Juno Therapeutics for $US9 billion. In 2019 Bristol-Myers Squibb bought Celgene for $US74 billion.
he turned viralytics over to merck at $1.75 a share (from 30c june 2014) in approx 4yrs....
WHO KNOWS....
Paull hopper has gathered a team of money makers again...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $19.57K | 4.893M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 419507 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18587873 | 22 |
View Market Depth
| Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |